The Association of Gut Microbiota and Treg Dysfunction in Autoimmune Diseases

Adv Exp Med Biol. 2021:1278:191-203. doi: 10.1007/978-981-15-6407-9_10.

Abstract

Autoimmune conditions affect 23 million Americans or 7% of the US population. There are more than 100 autoimmune disorders, affecting every major organ system in humans. This chapter aims to further explain Treg dysfunction autoimmune disorders, including monogenic primary immune deficiency such as immune dysregulation polyendocrinopathy, enteropathy, X-linked inheritance (IPEX) syndrome, and polygenic autoimmune diseases with Treg dysfunction such as multiple sclerosis (MS), inflammatory bowel disease (IBD), and food allergy. These conditions are associated with an abnormal small intestinal and colonic microbiome. Some disorders clearly improve with therapies aimed at microbial modification, including probiotics and fecal microbiota transplantation (FMT). Approaches to prevent and treat these disorders will need to focus on the acquisition and maintenance of a healthy colonic microbiota, in addition to more focused approaches at immune suppression during acute disease exacerbations.

Keywords: Dysbiosis; Immunodeficiency; Inflammatory bowel disease; Multiple sclerosis; Probiotic.

MeSH terms

  • Autoimmune Diseases* / therapy
  • Dysbiosis
  • Fecal Microbiota Transplantation
  • Gastrointestinal Microbiome*
  • Humans
  • Inflammatory Bowel Diseases*
  • T-Lymphocytes, Regulatory